Western blot analyses in both in vitro and in vivo demonstrated that BA treatment increased expression of Beclin1 and LC3B proteins, while significantly decreasing expression of PI3K, AKT, mTOR, and MAPK proteins in murine melanoma cells. The gene discussed is BECN1; the disease is melanoma.